TY - JOUR
T1 - Effects of sinoaortic denervation on the reflex actions of digoxin and a polar aminocardenolide
AU - Rebagay, Winona R.
AU - Caldwell, Robert W.
PY - 1992/1
Y1 - 1992/1
N2 - To determine the role of carotid sinus and aortic arch baroreceptors in the reflex cardiac sympathetic nerve activity (SNA) responses to administration of ASI-222, a polar aminocardenolide, and to digoxin, a neutral cardenolide, we used anesthetized dogs from which these reflex receptor areas had been removed. The SNA was measured in postganglionic fibers from the stellate ganglion. After we made baseline measurements, we infused either ASI-222 or digoxin intravenously (i.v.) at dose rates that produce cardiac arrhythmias in -100 min (0.7 and 1.2 μg/kg/min), respectively. Our data indicate that with sinoaortic baroreceptors removed, progressive infusion of digoxin increases cardiac SNA. In contrast, cardiac SNA decreases progressively during continuous infusion of ASI-222. In saline-treated dogs, SNA was not significantly altered. In another series of experiments, we examined the effects of these drugs and saline on cardiac vagal afferent nerve activity (VANA). ASI-222 (50 μg/kg i.v. in 10 min) caused a progressive increase in cardiac VANA in a 60-min observation period. Neither digoxin, at 120 μg/kg i.v. in 100 min, nor saline altered VANA. Digoxin appears to reduce SNA by interacting with the carotid sinus and aortic arch baroreceptors, which are myelinated. It does not affect VANA acutely. In contrast, ASI-222 appears to decrease cardiac SNA by interacting with other reflex receptor areas-the unmyelinated cardiopulmonary afferent nerve endings, particularly cardiac mechanoreceptors.
AB - To determine the role of carotid sinus and aortic arch baroreceptors in the reflex cardiac sympathetic nerve activity (SNA) responses to administration of ASI-222, a polar aminocardenolide, and to digoxin, a neutral cardenolide, we used anesthetized dogs from which these reflex receptor areas had been removed. The SNA was measured in postganglionic fibers from the stellate ganglion. After we made baseline measurements, we infused either ASI-222 or digoxin intravenously (i.v.) at dose rates that produce cardiac arrhythmias in -100 min (0.7 and 1.2 μg/kg/min), respectively. Our data indicate that with sinoaortic baroreceptors removed, progressive infusion of digoxin increases cardiac SNA. In contrast, cardiac SNA decreases progressively during continuous infusion of ASI-222. In saline-treated dogs, SNA was not significantly altered. In another series of experiments, we examined the effects of these drugs and saline on cardiac vagal afferent nerve activity (VANA). ASI-222 (50 μg/kg i.v. in 10 min) caused a progressive increase in cardiac VANA in a 60-min observation period. Neither digoxin, at 120 μg/kg i.v. in 100 min, nor saline altered VANA. Digoxin appears to reduce SNA by interacting with the carotid sinus and aortic arch baroreceptors, which are myelinated. It does not affect VANA acutely. In contrast, ASI-222 appears to decrease cardiac SNA by interacting with other reflex receptor areas-the unmyelinated cardiopulmonary afferent nerve endings, particularly cardiac mechanoreceptors.
KW - Aminocardenolide
KW - Autonomic reflexes
KW - Digoxin
KW - Sinoaortic denervation
UR - http://www.scopus.com/inward/record.url?scp=0026556804&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026556804&partnerID=8YFLogxK
U2 - 10.1097/00005344-199201000-00007
DO - 10.1097/00005344-199201000-00007
M3 - Article
C2 - 1375687
AN - SCOPUS:0026556804
SN - 0160-2446
VL - 19
SP - 45
EP - 51
JO - Journal of Cardiovascular Pharmacology
JF - Journal of Cardiovascular Pharmacology
IS - 1
ER -